Literature DB >> 8406844

Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis.

P Probst1, E Hermann, K H Meyer zum Büschenfelde, B Fleischer.   

Abstract

The local T-cell response to bacterial antigens is involved in the pathogenesis of reactive arthritis (ReA). Here, we have identified a 19-kDa antigen of Yersinia enterocolitica O:9 recognized by Yersinia-specific synovial fluid CD4+ T cells in two patients with Yersinia-induced ReA. N-terminal amino acid sequencing of this protein revealed that it was identical to the 19-kDa urease beta subunit of Y. enterocolitica O:9. This protein has previously been shown to be arthritogenic in preimmunized rats after intra-articular injection. Analysis of the T-cell response to this protein showed that it contains several T-cell epitopes, one of which cross-reacts with other enterobacteria not able to induce ReA. This indicates that the arthritogenicity of the 19-kDa antigen is not a property of the 19-kDa protein alone but is dependent on its expression in bacteria able to induce ReA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406844      PMCID: PMC281190          DOI: 10.1128/iai.61.10.4507-4509.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis.

Authors:  M Hammer; H Zeidler; S Klimsa; J Heesemann
Journal:  Arthritis Rheum       Date:  1990-12

Review 2.  Intracellular pathogens and professional phagocytes in reactive arthritis.

Authors:  M Wuorela; S Jalkanen; P Toivanen; K Granfors
Journal:  Pathobiology       Date:  1991       Impact factor: 4.342

3.  Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis.

Authors:  A M Viitanen; T P Arstila; R Lahesmaa; K Granfors; M Skurnik; P Toivanen
Journal:  Arthritis Rheum       Date:  1991-01

4.  Synovial T lymphocyte recognition of organisms that trigger reactive arthritis.

Authors:  J S Gaston; P F Life; K Granfors; R Merilahti-Palo; L Bailey; S Consalvey; A Toivanen; P A Bacon
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis.

Authors:  E Hermann; B Fleischer; W J Mayet; T Poralla; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

Review 6.  Reiter's syndrome and reactive arthritis in perspective.

Authors:  A Keat
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

7.  Lymphocytes from the site of disease but not blood lymphocytes indicate the cause of arthritis.

Authors:  D K Ford; D da Roza; M Schulzer
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

8.  Isolation of Yersinia-specific T cell clones from the synovial membrane and synovial fluid of a patient with reactive arthritis.

Authors:  N J Viner; L C Bailey; P F Life; P A Bacon; J S Gaston
Journal:  Arthritis Rheum       Date:  1991-09

9.  Cationic Yersinia antigen-induced chronic allergic arthritis in rats. A model for reactive arthritis in humans.

Authors:  A K Mertz; S R Batsford; E Curschellas; M J Kist; K B Gondolf
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; R von Essen; R Lahesmaa-Rantala; O Isomäki; K Pekkola-Heino; R Merilahti-Palo; R Saario; H Isomäki; A Toivanen
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

View more
  16 in total

1.  Construction of urease-negative mutants of Yersinia enterocolitica serotypes O:3 and o:8: role of urease in virulence and arthritogenicity.

Authors:  C Gripenberg-Lerche; L Zhang; P Ahtonen; P Toivanen; M Skurnik
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Severe myelitis following infection with Campylobacter enteritis.

Authors:  J Aberle; J Kluwe; F Pawlas; H J Stellbrink; H Greten
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-15       Impact factor: 3.267

Review 3.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 4.  HLA-B27 and bacteria.

Authors:  J Uksila; P Toivanen
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

5.  Urease from a potentially pathogenic coccoid isolate: purification, characterization, and comparison to other microbial ureases.

Authors:  S G Lee; D H Calhoun
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  Human gamma delta T-cell recognition of Yersinia enterocolitica.

Authors:  J L Young; J C Goodall; H Beacock-Sharp; J S Gaston
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

Review 7.  T-cell studies in the spondyloarthropathies.

Authors:  E Märker-Hermann; P Schwab
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

Review 8.  Cytokines and the immunopathology of the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

9.  Urease is not involved in the virulence of Yersinia pseudotuberculosis in mice.

Authors:  B Riot; P Berche; M Simonet
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

10.  The evolutionarily conserved ribosomal protein L23 and the cationic urease beta-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in Yersinia-triggered reactive arthritis: implications for autoimmunity.

Authors:  A K Mertz; A Daser; M Skurnik; K H Wiesmüller; J Braun; H Appel; S Batsford; P Wu; A Distler; J Sieper
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.